Allspring Global Investments’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$493K Buy
15,224
+1,557
+11% +$57.6K ﹤0.01% 1393
2025
Q4
$579K Buy
13,667
+1,185
+9% +$47.8K ﹤0.01% 1336
2025
Q3
$452K Sell
12,482
-122
-1% -$3.5K ﹤0.01% 1377
2025
Q2
$344K Sell
12,604
-934
-7% -$27.1K ﹤0.01% 1440
2025
Q1
$400K Buy
13,538
+4,792
+55% +$183K ﹤0.01% 1515
2024
Q4
$354K Buy
8,746
+20
+0.2% +$757 ﹤0.01% 1545
2024
Q3
$297K Sell
8,726
-2,339
-21% -$65.8K ﹤0.01% 1597
2024
Q2
$240K Buy
11,065
+1,740
+19% +$36.6K ﹤0.01% 1675
2024
Q1
$207K Buy
9,325
+778
+9% +$19K ﹤0.01% 1698
2023
Q4
$235K Sell
8,547
-14,223
-62% -$343K ﹤0.01% 1660
2023
Q3
$508K Sell
22,770
-54,542
-71% -$1.4M ﹤0.01% 1524
2023
Q2
$1.97M Buy
77,312
+72,104
+1,384% +$1.75M ﹤0.01% 1240
2023
Q1
$116K Buy
5,208
+2,036
+64% +$49.2K ﹤0.01% 1994
2022
Q4
$75.3K Sell
3,172
-5
-0.2% -$116 ﹤0.01% 2184
2022
Q3
$52K Sell
3,177
-782
-20% -$17.6K ﹤0.01% 2340
2022
Q2
$78K Sell
3,959
-100,988
-96% -$2.04M ﹤0.01% 2132
2022
Q1
$2.89M Buy
104,947
+9,930
+10% +$284K ﹤0.01% 1337
2021
Q4
$3.91M Buy
+95,017
New +$4.2M ﹤0.01% 1262

Other funds holding VCYT

Allspring Global Investments's VCYT Position: Q1 2026 in Review

Allspring Global Investments increased its Veracyte (VCYT) stake by 11% in Q1 2026, buying an estimated $57.6K and bringing the position to 15,224 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1393.

Allspring Global Investments first reported a position in VCYT in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.91M in Q4 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Allspring Global Investments held 15,224 shares of Veracyte worth $493K as of Q1 2026.
  • Allspring Global Investments bought 1,557 Veracyte shares in Q1 2026, an estimated $57.6K.
  • Veracyte made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1393 holding.
  • Allspring Global Investments first reported a position in Veracyte in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Veracyte position peaked at $3.91M in Q4 2021.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.